The objective of this clinical trial is to show that PEMF therapy, heat, recovery metrics, and compliance data provided by the OrthoCor Advanced System improves pain and quality of life for patients with osteoarthritis. The main question it aims to answer is:
Does therapy from the OrthoCor Advanced System improve symptoms of osteoarthritis?
Researchers will compare range of motion measurements, sit to stand test results, and functional survey answers to see if there are any changes after 4 weeks of therapy with the OrthoCor Advanced System.
Participants will use the OrthoCor Active System for 30 minutes twice daily and complete recovery measurements daily using an application.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Presenting to the study site with knee pain for at least 3 months, with articular cartilage loss confirmed by imaging study
✓. An initial pain VAS score \>4
✓. At least 2 hours of daily standing and/or walking activity
✓. Prescribed use of the OrthoCor Advanced System
✓. Daily access to a smartphone or tablet compatible with the OrthoCor Medical application
✓. Able to download and install app to smart phone
✓. Willing and able to provide written consent
✓. ≥18 years of age
Exclusion criteria
✕. Previous diagnosis of rheumatoid arthritis or gout
✕. Cortisone injection, knee surgery, or viscosupplementation in the previous 6 months
✕
What they're measuring
1
Adverse Events
Timeframe: during 4 weeks of treatment
2
VAS pain score
Timeframe: before, during, and after 4 weeks of treatment